NetraMark Holdings Inc. offers AI-driven insights and software solutions for clinical research and biotechnology sectors. While the company boasts a strong liquidity position with a current ratio of 7.70 and no debt, its financial health is concerning, highlighted by a significant negative EBITDA and net margin of -336.9%, indicating ongoing operational challenges. Additionally, the return on equity and assets are both deeply negative, raising questions about profitability. Overall, while liquidity is a strength, the company's financial performance needs improvement to attract investor confidence.
Loading financial metrics...
Company is burning $1.3M per quarter with $3.2M in cash. Approximately 2.5 quarters of runway at current burn rate.
Company posted a loss of $-6.5M over the last year, representing 1070.5% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $5.0M over the last year.
Exceptional revenue growth of 57.0% YoY demonstrates strong market demand and competitive positioning.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Excellent liquidity with current ratio of 7.7x ensures operational stability.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Health Information Services companies of a similar size
Based on 2026-Q3 (June 30, 2026)